Evaluation of theranostic nanocarriers for near-infrared imaging and photodynamic therapy on human prostate cancer cells

Colloids and Surfaces B: Biointerfaces

Volumn 154, Issue , 2017, Pages 341-349

  Leandro, Fernanda Z ^a   Martins, Júlia ^a   Fontes, Aparecida M ^a   Tedesco, Antonio C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chloroaluminum phthalocyanine; Colloidal nanocarriers; Photodiagnosis; Photodynamic therapy; Prostate cancer; Theranostics

Indexed keywords

BIOCOMPATIBILITY; CYTOLOGY; DIAGNOSIS; DISEASES; FLUORESCENCE; INFRARED DEVICES; INFRARED IMAGING; NITROGEN COMPOUNDS; PHOTODYNAMIC THERAPY; PHOTOSENSITIZERS; PROTEINS; THERMOGRAPHY (IMAGING); UROLOGY;

CHLOROALUMINUM PHTHALOCYANINE; NANO-CARRIERS; PHOTODIAGNOSIS; PROSTATE CANCERS; THERANOSTICS;

CELLS;

CHLOROALUMINUM PHTHALOCYANINE; NANOCAPSULE; DRUG CARRIER; INDOLE DERIVATIVE; ORGANOMETALLIC COMPOUND; PHOTOSENSITIZING AGENT;

ACTIN FILAMENT; ARTICLE; CELL STRUCTURE; CELL VIABILITY; CELLULAR DISTRIBUTION; CONFOCAL IMAGING; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMAGING AND DISPLAY; IN VITRO STUDY; MALE; MITOCHONDRION; NANOEMULSION; NEAR INFRARED IMAGING SYSTEM; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PROSTATE CANCER CELL LINE; THERANOSTIC NANOMEDICINE; CELL SURVIVAL; CHEMISTRY; CONFOCAL MICROSCOPY; DRUG EFFECTS; EMULSION; EPITHELIUM CELL; LIGHT; PATHOLOGY; PHOTOCHEMOTHERAPY; PROCEDURES; PROSTATE; TUMOR CELL LINE; ULTRASTRUCTURE;

ACTIN CYTOSKELETON; CELL LINE, TUMOR; CELL SURVIVAL; DRUG CARRIERS; EMULSIONS; EPITHELIAL CELLS; HUMANS; INDOLES; LIGHT; MALE; MICROSCOPY, CONFOCAL; MITOCHONDRIA; NANOCAPSULES; ORGANOMETALLIC COMPOUNDS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROSTATE; THERANOSTIC NANOMEDICINE;

EID: 85016415441     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2017.03.042     Document Type: Article

References (38)

1. [1] Siegel, R.L., Miller, K.D., Jemal, A., Statistics, Cancer, CA Cancer J. Clin. 67:2017 (2017), 7–30.
2. [2] Holtz, J.N., Tay, K.J., Polascik, T.J., Gupta, R.T., Integration of multiparametric MRI into active surveillance of prostate cancer. Future Oncol. 12 (2016), 2513–2529.
3. [3] León-Mateos, L., Vieito, M., Anido, U., López, R.L., Romay, L.M., Clinical application of circulating tumour cells in prostate cancer: from bench to bedside and back. Int. J. Mol. Sci. 17 (2016), 1580–1595.
4. [4] Moore, C.M., Pendse, D., Emberton, M., Photodynamic therapy for prostate cancer – a review of current status and future promise. Nat. Clin. Pract. Urol. 6 (2009), 18–30.
5. [5] Taratula, O., Schumann, C., Naleway, M.A., Pang, A.J., Chon, K.J., Taratula, O., A multifunctional theranostic platform based on phthalocyanine-loaded dendrimer for image-guided drug delivery and photodynamic therapy. Mol. Pharm. 10 (2013), 3946–3958.
6. [6] Huang, P., Lin, J., Wang, Z., Zhang, C., He, M., Wang, K., Chen, F., Li, Z., Shen, G., Cui, D., Chen, X., Light-triggered theranostics based on photosensitizer-conjugated carbon dots for simultaneous enhanced-fluorescence imaging and photodynamic therapy. Adv. Mater. 24 (2012), 5104–5110.
7. [7] Josefsen, L.B., Boyle, R.W., Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranostics. Theranostics 2 (2012), 916–966.
8. [8] Windahl, T., Andersson, S.O., Lofgren, L., Photodynamic therapy of localised prostatic cancer. Lancet, 336, 1990, 1139.
9. [9] Agostinis, P., Berg, K., Cengel, K.A., Foster, T.H., Girotti, A.W., Gollnick, S.O., Hahn, S.M., Hamblin, M.R., Juzeniene, A., Kessel, D., Korbelik, M., Moan, J., Mroz, P., Nowis, D., Piette, J., Wilson, B.C., Golab, J., Photodynamic therapy of cancer: an update. CA Cancer J. Clin. 61 (2011), 250–281.
10. [10] Dolmans, D.E.J.G.G., Fukumura, D., Jain, R.K., Photodynamic therapy for cancer. Nat. Rev. Cancer 3 (2003), 380–387.
11. [11] Davids, L.M., Kleemann, B., Combating melanoma: the use of photodynamic therapy as a novel adjuvant therapeutic tool. Cancer Treat. Rev. 37 (2011), 465–475.
12. [12] Xia, C., Wang, Y., Chen, W., Yu, W., Wang, B., Li, T., New hydrophilic/lipophilic tetra-α-(4-carboxyphenoxy) phthalocyanine zinc-mediated photodynamic therapy inhibits the proliferation of human hepatocellular carcinoma bel-7402Cells by triggering apoptosis and arresting cell cycle. Molecules 16 (2011), 1389–1401.
13. [13] Sekkat, N., van den Bergh, H., Nyokong, T., Lange, N., Like a bolt from the blue: phthalocyanines in biomedical optics. Molecules 17 (2012), 98–144.
14. [14] Pansare, V.J., Hejazi, S., Faenza, W.J., Prud'homme, R.K., Review of long-wavelength optical and NIR imaging materials: contrast agents, fluorophores, and multifunctional nano carriers. Chem. Mater. 24 (2012), 812–827.
15. [15] Moeno, S., Nyokong, T., An investigation of the behavior of quaternized peripherally tetra mercaptopyridine substituted metallophtalocyanines in the presence of quantum dots. J. Photochem. Photobiol. A 215 (2010), 196–204.
16. [16] Ali, H., van Lier, J.E., Metal complexes as photo- and radiosensitizers. Chem. Rev. 99 (1999), 2379–2450.
17. [17] Castano, A.P., Demidova, T.N., Hamblin, M.R., Mechanisms in photodynamic therapy: part one: photosensitizers, photochemistry and cellular localization. Photodiagnosis Photodyn. Ther. 1 (2004), 279–293.
18. [18] Howe, L., Zhang, J.Z., Ultrafast studies of excited-state dynamics of phthalocyanine and zinc phthalocyanine tetrasulfonate in solution. J. Phys. Chem. A 101 (1997), 3207–3213.
19. [19] DeRosa, M.C., Crutchley, R.J., Photosensitized singlet oxygen and its applications. Coord. Chem. Rev. 233–234 (2002), 351–371.
20. [20] Brown, S.B., Brown, E.A., Walker, I., The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol. 5 (2004), 497–508.
21. [21] Duchi, S., Ramos-Romero, S., Dozza, B., Guerra-Rebollo, M., Cattini, L., Ballestri, M., Dambruoso, P., Guerrini, A., Sotgiu, G., Varchi, G., Lucarelli, E., Blanco, J., Development of near-infrared photoactivable phthalocyanine-loaded nanoparticles to kill tumor cells: an improved tool for photodynamic therapy of solid cancers. Nanomed. Nanotechnol. Biol. Med. 12 (2016), 1885–1897.
22. [22] Py-Daniel, K.R., Namban, J.S., Andrade, L.R., Souza, P.E.N., Paterno, L.G., Azevedo, R.B., Soler, M.A.G., Highly efficient photodynamic therapy colloidal system based on chloroaluminum phthalocyanine/pluronic micelles. Eur. Pharm. Biopharm. 103 (2016), 23–31.
23. [23] Muehlmann, L.A., Ma, B.C., Longo, J.P.F., Menezes, M.F., Santos, A., Azevedo, R.B., Aluminum-phthalocyanine chloride associated to poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as a new third-generation photosensitizer for anticancer photodynamic therapy. Int. J. Nanomed. 9 (2014), 1199–1213.
24. [24] Silva, E.P.O., Franchi, L.P., Tedesco, A.C., Chloro-aluminum phthalocyanine loaded in ultradeformable liposomes for photobiology studies on human glioblastoma. RSC Adv. 6 (2016), 79631–79640.
25. [25] Longo, J.P.F., Muehlmann, L.A., Miranda-Vilela, A.L., Portilho, F.A., Souza, L.R., Silva, J.R., Lacava, Z.G.M., Bocca, A.L., Chaves, S.B., Azevedo, R.B., Prevention of distant lung metastasis after photodynamic therapy application in a breast cancer tumor model. J. Biomed. Nanotechnol. 12 (2016), 689–699.
26. [26] Longo, J.P.F., Melo, L.N.D., Mijan, M.C., Valois, C.R.A., Joanitti, G.A., Simioni, A.R., Tedesco, A.C., Azevedo, R.B., Photodynamic therapy mediated by liposomal chloroaluminum-phthalocyanine induces necrosis in oral cancer cells. J. Biomater. Tissue Eng. 3 (2013), 148–156.
27. [27] Siqueira-Moura, M.P., Primo, F.L., Espreafico, E.M., Tedesco, A.C., Development characterization, and photocytotoxicity assessment on human melanoma of chloroaluminum phthalocyanine nanocapsules. Mater. Sci. Eng. C 33 (2013), 1744–1752.
28. [28] Primo, F.L., Reis, M.B.C., Porcionatto, M.A., Tedesco, A.C., In vitro evaluation of chloroaluminum phthalocyanine nanoemulsion and low- level laser therapy on human skin dermal equivalents and bone marrow mesenchymal stem cells. Curr. Med. Chem. 18 (2011), 3376–3381.
29. [29] Miller, J.D., Baron, E.D., Scull, H., Hsia, A., Berlin, J.C., McCornick, T., Colussi, V., Kenney, M.E., Cooper, K.D., Oleinick, N.L., Photodynamic therapy with the phthalocyanine photosensitizer Pc 4: the case experience with preclinical mechanistic and early clinical-translational studies. Toxicol. Appl. Pharmacol. 224 (2007), 290–299.
30. [30] Denizot, F., Lang, R., Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 89 (1986), 271–277.
31. [31] Schindelin, J., Arganda-Carreas, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmide, B., Tinevez, J.Y., White, D.J., Hartenstein, V., Eliceiri, K., Tomancak, P., Cardona, A., Fiji: an open-source platform for biological-image analysis. Nat. Methods 9 (2012), 676–682.
32. [32] Bolte, S., Cordelières, F.P., A guided tour into subcellular colocalization analysis in light microscopy. J. Microsc. 224 (2006), 213–232.
33. [33] Hines, D.J., Kaplan, D.L., Poly (lactic-co-glycolic acid) controlled release systems: experimental and modeling insights. Crit. Rev. Ther. Drug Carrier Syst. 30 (2013), 257–276.
34. [34] Makadia, H.K., Siegel, S.J., Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers (Basel) 3 (2011), 1377–1397.
35. [35] Lü, J.M., Wang, X., Marin-Muller, C., Wang, H., Lin, P.H., Yao, Q., Chen, C., Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Rev. Mol. Diagn. 9 (2009), 325–341.
36. [36] Oleinick, N.L., Morris, R.L., Belichenko, I., The role of apoptosis in response to photodynamic therapy: what, where, why, and how. Photochem. Photobiol. Sci. 1 (2002), 1–21.
37. [37] Silva, A.R., Inada, N.M., Rettori, D., Baratti, M.O., Vercesi, A.E., Jorge, R.A., In vitro photodynamic activity of chloro(5,10,15-20-tetraphenylporphyrinato)indium(III) loaded-poly(lactide-co-glycolide) nanoparticles in LNCaP prostate tumour cells. J. Photochem. Photobiol. B 94 (2009), 101–112.
38. ® and Fospeg in a human prostate cancer cell line. Photodiagn. Photodyn. Ther. 9 (2012), 344–354.